Effectiveness and Cost-Effectiveness of Dialectical Behaviour Therapy for Self-Harming Patients with Personality Disorder: A Pragmatic Randomised Controlled Trial

被引:103
作者
Priebe, Stefan [1 ]
Bhatti, Nyla [2 ]
Barnicot, Kirsten
Bremner, Stephen
Gaglia, Amy [2 ]
Katsakou, Christina [2 ]
Molosankwe, Iris [3 ]
McCrone, Paul [3 ]
Zinkler, Martin
机构
[1] Queen Mary Univ London, Unit Social & Community Psychiat, Barts & London Sch Med & Dent, Newham Ctr Mental Hlth, London E13 8SP, England
[2] E London NHS Fdn Trust, London, England
[3] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
基金
美国国家卫生研究院;
关键词
Dialectical behaviour therapy; Borderline personality disorder; Self-harm; Cost-effectiveness; TREATMENT COMPLETION; RATING-SCALE; HEALTH-CARE; REAL-WORLD; FOLLOW-UP; DSM-IV; WOMEN; PSYCHOTHERAPY; METAANALYSIS; DIRECTIONS;
D O I
10.1159/000338897
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: A primary goal of dialectical behaviour therapy (DBT) is to reduce self-harm, but findings from empirical studies are inconclusive. The aim of this study was to assess the effectiveness and cost-effectiveness of DBT in reducing self-harm in patients with personality disorder. Methods: Participants with a personality disorder and at least 5 days of self-harm in the previous year were randomised to receive 12 months of either DBT or treatment as usual (TAU). The primary outcome was the frequency of days with self-harm; secondary outcomes included borderline personality disorder symptoms, general psychiatric symptoms, subjective quality of life, and costs of care. Results: Forty patients each were randomised to DBT and TAU. In an intention-to-treat analysis, there was a statistically significant treatment by time interaction for self-harm (incidence rate ratio 0.91, 95% CI 0.89-0.92, p < 0.001). For every 2 months spent in DBT, the risk of self-harm decreased by 9% relative to TAU. There was no evidence of differences on any secondary outcomes. The economic analysis revealed a total cost of a mean of 5,685 GBP (6,786 EUR) in DBT compared to a mean of 3,754 GBP (4,481 EUR) in TAU, but the difference was not significant (95% CI -603 to 4,599 GBP). Forty-eight per cent of patients completed DBT. They had a greater reduction in self-harm compared to dropouts (incidence rate ratio 0.78, 95% CI 0.76-0.80, p < 0.001). Conclusions: DBT can be effective in reducing self-harm in patients with personality disorder, possibly incurring higher total treatment costs. The effect is stronger in those who complete treatment. Future research should explore how to improve treatment adherence. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:356 / 365
页数:10
相关论文
共 50 条
  • [41] The Effectiveness of Dialectical Behavior Therapy Compared to Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial
    Assmann, Nele
    Schaich, Anja
    Arntz, Arnoud
    Wagner, Till
    Herzog, Philipp
    Alvarez-Fischer, Daniel
    Sipos, Valerija
    Jauch-Chara, Kamila
    Klein, Jan Philipp
    Hueppe, Michael
    Schweiger, Ulrich
    Fassbinder, Eva
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2024, 93 (04) : 249 - 263
  • [42] A Review Comparing Dialectical Behavior Therapy and Mentalization for Adolescents with Borderline Personality Traits, Suicide and Self-harming Behavior
    Olga Karagiorgou Johnstone
    John J. Marshall
    Lindsey Gilling McIntosh
    Adolescent Research Review, 2022, 7 : 187 - 209
  • [43] A Review Comparing Dialectical Behavior Therapy and Mentalization for Adolescents with Borderline Personality Traits, Suicide and Self-harming Behavior
    Johnstone, Olga Karagiorgou
    Marshall, John J.
    McIntosh, Lindsey Gilling
    ADOLESCENT RESEARCH REVIEW, 2022, 7 (02) : 187 - 209
  • [44] Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: design of a pragmatic randomised controlled trial
    Biesheuvel-Leliefeld, Karolien E. M.
    Kersten, Sandra M. A.
    van der Horst, Henriette E.
    van Schaik, Anneke
    Bockting, Claudi L. H.
    Bosmans, Judith E.
    Smit, Filip
    van Marwijk, Harm W. J.
    BMC PSYCHIATRY, 2012, 12
  • [45] Suicidal and Self-Harming Behaviors in Patients With Borderline Personality Disorder With and Without Eating Disorders
    Tennenhouse, Rachel
    Ruocco, Anthony C.
    Mcmain, Shelley F.
    Sonley, Anne
    JOURNAL OF PERSONALITY DISORDERS, 2025, 39 (01) : 48 - 60
  • [46] A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of Well Parent Japan in routine care in Japan: The training and nurturing support for mothers (TRANSFORM) study
    Shimabukuro, Shizuka
    Oshio, Takashi
    Endo, Takahiro
    Harada, Satoshi
    Yamashita, Yushiro
    Tomoda, Akemi
    Guo, Boliang
    Goto, Yuko
    Ishii, Atsuko
    Izumi, Mio
    Nakahara, Yukiko
    Yamamoto, Kazushi
    Daley, David
    Tripp, Gail
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2024, 65 (12) : 1624 - 1637
  • [47] Cost-effectiveness of exercise as a therapy for behavioural and psychological symptoms of dementia within the EVIDEM-E randomised controlled trial
    D'Amico, Francesco
    Rehill, Amritpal
    Knapp, Martin
    Lowery, David
    Cerga-Pashoja, Arlinda
    Griffin, Mark
    Iliffe, Steve
    Warner, James
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 31 (06) : 656 - 665
  • [48] Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial
    Hurtado-Santiago, Silvia
    Guzman-Parra, Jose
    Bersabe, Rosa M.
    Mayoral, Fermin
    BMC PSYCHIATRY, 2018, 18
  • [49] Effectiveness and cost-effectiveness of web-based treatment for phobic outpatients on a waiting list for psychotherapy: protocol of a randomised controlled trial
    Kok, Robin N.
    van Straten, Annemieke
    Beekman, Aartjan
    Bosmans, Judith
    de Neef, Manja
    Cuijpers, Pim
    BMC PSYCHIATRY, 2012, 12
  • [50] The effectiveness and cost-effectiveness of attachment-based family therapy for young adults with high suicidal ideation: protocol of a randomized controlled trial
    Bockting, Claudi
    Bosmans, Guy
    Bergers, Nele
    Gavan, Luana
    Hiligsmann, Mickael
    de Beurs, Derek
    Molenberghs, Geert
    Wijnen, Ben
    Lokkerbol, Joran
    van der Spek, Nadia
    TRIALS, 2024, 25 (01)